| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 397 |
| 1 | CAPECITABINE | 176 |
| 2 | PROPOFOL | 167 |
| 3 | FLUOROURACIL | 118 |
| 4 | FLUOROURACIL CREAM, 0.5% | 118 |
| 5 | FENTANYL | 114 |
| 6 | ONDANSETRON HYDROCHLORIDE | 109 |
| 7 | ONDANSETRON | 93 |
| 8 | DEXAMETHASONE | 90 |
| 9 | DEXAMETHASONE 1.5 MG | 90 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CENTRUROIDES (SCORPION) IMMUNE F(AB)2 (EQUINE) | 2 | 0.1053 |
| 1 | ARTICAINE HYDROCHLORIDE, EPINEPHRINE BITARTRATE | 1 | 0.0270 |
| 2 | SUGAMMADEX SODIUM | 31 | 0.0234 |
| 3 | NAXITAMAB | 5 | 0.0200 |
| 4 | NEOSTIGMINE METHYLSULFATE | 7 | 0.0162 |
| 5 | SUGAMMADEX | 40 | 0.0146 |
| 6 | DESFLURANE | 22 | 0.0128 |
| 7 | APADAMTASE ALFA | 1 | 0.0127 |
| 8 | NITROUS OXIDE | 27 | 0.0122 |
| 9 | REMIFENTANIL HYDROCHLORIDE | 28 | 0.0116 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 461 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 300 |
| 2 | Corticosteroid [EPC] | 256 |
| 3 | General Anesthetic [EPC] | 212 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 162 |
| 5 | Benzodiazepine [EPC] | 159 |
| 6 | Opioid Agonist [EPC] | 135 |
| 7 | Serotonin-3 Receptor Antagonist [EPC] | 123 |
| 8 | Proton Pump Inhibitor [EPC] | 109 |
| 9 | Atypical Antipsychotic [EPC] | 100 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antivenin [EPC] | 2 | 0.1053 |
| 1 | Interleukin-5 Antagonist [EPC] | 8 | 0.0116 |
| 2 | Cholecystokinin Analog [EPC] | 1 | 0.0065 |
| 3 | General Anesthetic [EPC] | 212 | 0.0049 |
| 4 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 5 | 0.0046 |
| 5 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 3 | 0.0024 |
| 6 | Anticholinergic [EPC] | 28 | 0.0017 |
| 7 | Platinum-based Drug [EPC] | 461 | 0.0017 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 14 | 0.0016 |
| 9 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |